Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.
about
Antiseptics and disinfectants: activity, action, and resistanceCellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteriaAntimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophagesExtracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complexAction of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanineIn vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacinCharacterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activityActivities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complexActivities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium aviumRole of embB in natural and acquired resistance to ethambutol in mycobacteriaModulation of Mycobacterium tuberculosis proliferation by MtrA, an essential two-component response regulatorAntimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains.Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosisSparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents.French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complexRecognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.Epidemiology of infection by nontuberculous mycobacteriaOverexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.The Mycobacterium avium complexActivity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutolCell-free system responsible for internal radiolabeling of glycopeptidolipids of the Mycobacterium avium complex.Mycobacterium avium complex infection in HIV/AIDS patients.Predicting natural product value, an exploration of anti-TB drug space.Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.Do Shoot the Messenger: PASTA Kinases as Virulence Determinants and Antibiotic Targets.Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine.Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.Lactoferricin Peptides Increase Macrophages' Capacity To Kill Mycobacterium avium.Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.Enhanced biotransformation of sitosterol to androstenedione by Mycobacterium sp. using cell wall permeabilizing antibiotics.Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium.Permeability of the cell wall of Mycobacterium smegmatis.Evidence for a small anion-selective channel in the cell wall of Mycobacterium bovis BCG besides a wide cation-selective pore.
P2860
Q24550729-E9806ABF-6D39-476D-9F78-9C055AA6A99FQ28217016-EA28E18C-B13A-49C3-B6C6-8DB87FDF9FD2Q28322331-393A5303-9915-4BD9-92A9-6A7230EDF8F3Q28326449-64D7EF55-9E8C-47BA-A6AA-15C0BAF9DA06Q28328609-E819147F-911C-4575-AA2E-734167F403DFQ28333965-96FFAF82-E00E-43EF-9841-422D32112928Q28344469-19020C5F-582B-488E-9A05-EBB45CFA429AQ28369478-A420D574-5B32-4AD4-871C-A1418FF9D84EQ28378705-C96860C6-6F16-437D-B040-3621782383F5Q28379175-86DEE2D1-0171-4162-8ADA-0CC15F711C3CQ28487579-3E6A2D36-3B43-45B3-AE36-A8F4761FFE27Q33573152-BFA24E47-0BCC-4ADB-8F18-D9021220F403Q33630442-F41E817C-4C66-4EF8-9F79-5565D4FBD6E8Q33745057-8306D9C8-3DD7-43A8-86D6-C58F3E059ECEQ33760607-7F4993DE-694A-42B3-BE77-B0A39AD3FEC5Q33868685-26AB0112-C709-46BE-93B7-2962A8B88B2FQ35112232-CF88CA6B-B715-4D42-8F75-7AF9A84978D7Q35112369-74E4F868-911F-42D3-A764-1E53BAA5DA45Q35370226-59FB0D4D-6807-4A3B-A1DE-F67BD6D1D9C4Q35627816-E71C2AEA-55F1-4963-A6EA-90285FB81B17Q35817293-6225FBF0-ADC6-42D9-B81A-F22C7A8EFA5CQ36640345-3A26D2C6-7D3F-4704-9CA0-F4D6549E7933Q36758455-6C662AD3-9D62-4BBA-A6D6-8CAE62C63AA3Q36954663-9A7404F9-C244-4E74-873C-7B94CAF4C525Q37202852-4A245C76-0F68-499C-8DE9-18DE0FCCD9C3Q38216493-DCB9DA23-6800-4BB4-8E9F-4E0B0F0EFC33Q38634643-02AB336A-E792-411E-8678-0141C89FD2C3Q39451994-F8F4A833-1D54-45FF-864A-ECB892CDBB07Q39730806-BAC45BE9-7BCA-4DB8-8727-58E29C2BBF71Q39867298-62441F90-4B92-4417-9202-DE4E715147C9Q40065379-C31C8F44-3B1A-4393-8F69-D94FC8867519Q42285782-70BE1598-FB7A-4E31-9847-F71DDDE95FFFQ46419401-770B6DC4-5270-4140-8B1D-6509EB2E1F6DQ48038458-B7BD4D36-B51F-405D-9E9A-79FE9C56FD0CQ52370733-9A46CAFC-9A42-430D-8595-EE5FEA9EC970Q53927588-7CE7E920-99D9-426F-A363-0B321297DC46
P2860
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@en
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@nl
type
label
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@en
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@nl
prefLabel
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@en
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@nl
P2093
P2860
P356
P1476
Enhancement of drug susceptibi ...... rs of cell envelope synthesis.
@en
P2093
P2860
P304
P356
10.1128/AAC.34.5.759
P407
P577
1990-05-01T00:00:00Z